Abstract: Method for treating or preventing a PPAR-responsive condition in a subject, comprising administering to the subject a PPAR agonist that comprises a 8-hydroxyquinoline-methylene-N- group in an amount effective to activate a PPAR polypeptide.
PLEASE SEE THE SPECIFICATION ATTACHED.
| # | Name | Date |
|---|---|---|
| 1 | 5575-DELNP-2011-AbandonedLetter.pdf | 2018-01-24 |
| 1 | 5575-DELNP-2011-Form-13-(21-07-2011).pdf | 2011-07-21 |
| 2 | 5575-DELNP-2011-FER.pdf | 2017-05-30 |
| 2 | 5575-DELNP-2011-Correspondence-Others-(21-07-2011).pdf | 2011-07-21 |
| 3 | Form-5.pdf | 2011-08-21 |
| 3 | 5575-delnp-2011-Correspondence-others-(18-09-2012).pdf | 2012-09-18 |
| 4 | 5575-delnp-2011-Form-18-(18-09-2012).pdf | 2012-09-18 |
| 4 | Form-3.pdf | 2011-08-21 |
| 5 | Form-1.pdf | 2011-08-21 |
| 5 | 5575-delnp-2011-Correspondence Others-(23-12-2011).pdf | 2011-12-23 |
| 6 | 5575-delnp-2011-GPA-(23-12-2011).pdf | 2011-12-23 |
| 6 | 5575-delnp-2011-Form-3-(19-12-2011).pdf | 2011-12-19 |
| 7 | 5575-delnp-2011-Form-1-(19-12-2011).pdf | 2011-12-19 |
| 7 | 5575-delnp-2011-Correspondence-others-(19-12-2011).pdf | 2011-12-19 |
| 8 | 5575-delnp-2011-Form-1-(19-12-2011).pdf | 2011-12-19 |
| 8 | 5575-delnp-2011-Correspondence-others-(19-12-2011).pdf | 2011-12-19 |
| 9 | 5575-delnp-2011-GPA-(23-12-2011).pdf | 2011-12-23 |
| 9 | 5575-delnp-2011-Form-3-(19-12-2011).pdf | 2011-12-19 |
| 10 | 5575-delnp-2011-Correspondence Others-(23-12-2011).pdf | 2011-12-23 |
| 10 | Form-1.pdf | 2011-08-21 |
| 11 | 5575-delnp-2011-Form-18-(18-09-2012).pdf | 2012-09-18 |
| 11 | Form-3.pdf | 2011-08-21 |
| 12 | Form-5.pdf | 2011-08-21 |
| 12 | 5575-delnp-2011-Correspondence-others-(18-09-2012).pdf | 2012-09-18 |
| 13 | 5575-DELNP-2011-FER.pdf | 2017-05-30 |
| 13 | 5575-DELNP-2011-Correspondence-Others-(21-07-2011).pdf | 2011-07-21 |
| 14 | 5575-DELNP-2011-Form-13-(21-07-2011).pdf | 2011-07-21 |
| 14 | 5575-DELNP-2011-AbandonedLetter.pdf | 2018-01-24 |
| 1 | search_29-05-2017.PDF |